AZTR vs ZBH · $3.7M cap vs P/E 23, rev $4.26B
Azitra Inc (AZTR) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Azitra Inc (AZTR) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported AZTR revenue for 2025-12-31 was $0. Net income was -$11.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AZTR currently screens at market cap $3.7M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
AZTR currently screens at market cap $3.7M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the AZTR and ZBH stock pages for the full models.
Not investment advice.